A range of oral mucosal and periodontal lesions is associated with HIV infe
ction and HIV disease progression. These are often symptomatic and require
treatment in themselves, and also have a diagnostic and prognostic role in
the management of the underlying HIV disease. These lesions have been broad
ly divided into: (a) those strongly associated with HIV such as oral candid
oses, oral hairy leukoplakia and Kaposi's sarcoma; (b) those less strongly
associated such as swellings of the major salivary glands; and (c) those le
ast commonly associated such as recurrent aphthous ulcers, Overall the prev
alence and severity of these lesions inversely correlate with the level of
immunosuppression. With the passage of time, there has been improved unders
tanding of the disease pathogenesis resulting in the development of new dru
gs to combat this infection. Medication has changed from monotherapy to cur
rent triple combination therapy (Highly Active Anti-Retroviral Therapy), Th
is review looks at the impact of changing therapy on the prevalence of the
various oral lesions associated with HIV. It finds a decrease in the preval
ence of the oral lesions in the era of combination therapy as compared to e
arlier periods, It also shows a change in the types of lesions which predom
inate with those previously placed amongst the strongly associated lesions
no longer being predominant in the era of combination therapy where such tr
eatment is available.